Evidence map›Paper›PMID 21931488›Full record

ArticleInternational journal of nanomedicine2011

Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.

Cailian Wang, Haijun Zhang, Baoan Chen, Haitao Yin, Wenwen Wang

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. FeCell adhesion & migration · 2024
    Article
  2. Review
  3. Review
  4. Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  5. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.Biochimica et biophysica acta. Reviews on cancer · 2020
    Review
  6. Gambogic Acid as a Candidate for Cancer Therapy: A Review.International journal of nanomedicine · 2020
    Review
  7. Article
  8. Molecular targets of gambogic acid in cancer: recent trends and advancements.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cailian WangDepartment of Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People's Republic of China.
Haijun Zhang
Baoan Chen
Haitao Yin
Wenwen Wang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGambogic acid (GA), a potent anticancer agent, is limited in clinical administration due to its poor water solubility. The aim of this study was to explore a drug delivery system based on magnetic Fe(3)O(4) nanoparticles (MNP-Fe(3)O(4)) conjugated with GA to increase water solubility of the drug and enhance its chemotherapeutic efficiency for pancreatic cancer.

methodsGA was conjugated with the MNP-Fe(3)O(4) colloidal suspension by mechanical absorption polymerization to construct GA-loaded MNP-Fe(3)O(4), which acted as a drug delivery system.

resultsCombination therapy with GA and MNP-Fe(3)O(4) induced remarkable improvement in anticancer activity, which was demonstrated by optical microscopic observations, MTT assay, and nuclear DAPI staining. Furthermore, the possible signaling pathway was explored by Western blot. In Capan-1 pancreatic cancer cells, our observations demonstrated that this strategy could enhance potential anticancer efficiency by inducing apoptosis. The mechanisms of the synergistic effect may be due to reducing protein expression of Bcl-2 and enhancing that of Bax, caspase 9, and caspase 3.

conclusionThese findings demonstrate that a combination of GA and MNPs-Fe(3)O(4) represents a promising approach to the treatment of pancreatic cancer.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisbcl-2-Associated X ProteinCaspase 3Caspase 9Cell Line, TumorDrug CarriersDrug Delivery SystemsHumansMagnetite NanoparticlesModels, BiologicalNanomedicinePancreatic NeoplasmsProto-Oncogene Proteins c-bcl-2XanthonesAntineoplastic Agents, PhytogenicBAX protein, humanbcl-2-Associated X ProteinCASP3 protein, humanCASP9 protein, humanCaspase 3Caspase 9Drug Carriersgambogic acidMagnetite NanoparticlesProto-Oncogene Proteins c-bcl-2Xanthonesapoptosisdrug delivery systemgambogic acidmagnetic nanoparticlespancreatic cancer

Identifiers

PMID21931488
PMCPMC3173055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.